Literature DB >> 17293099

LTBP-2 specifically interacts with the amino-terminal region of fibrillin-1 and competes with LTBP-1 for binding to this microfibrillar protein.

Rena Hirani1, Eric Hanssen, Mark A Gibson.   

Abstract

LTBP-2 is a matrix protein of unknown function since, unlike other LTBPs, it does not form covalent complexes with latent TGF-beta. We have previously shown that LTBP-2 has widespread association with fibrillin-containing microfibrils in developing aorta and other tissues. We have now shown that full-length human recombinant LTBP-2 specifically binds to the amino-terminal region of fibrillin-1, but not to fibrillin-2, in solid phase assays and overlay blotting. The binding was enhanced by the inclusion of 2 mM Ca2+ ions in the assay buffer and abolished by 5 mM EDTA indicating that the interaction was directly or indirectly Ca2+ ion dependent. The K(d) for the interaction was calculated from the specific binding curve as 9.4 nM. A recombinant carboxyl-terminal fragment of LTBP-2 was shown to a) bind the amino-terminal fragment of fibrillin-1 and b) block completely the binding of full length LTBP-2 to fibrillin-1. This result indicates that the major fibrillin-1 binding site resides close to the carboxyl-terminus of LTBP-2. Further competitive binding studies showed that an analogous carboxyl terminal fragment of LTBP-1 was able to block the binding of LTBP-2 to fibrillin-1 and that the C-terminal fragment of LTBP-2 could block the interaction of the LTBP-1 fragment with the fibrillin. Thus the binding site for LTBP-2 on fibrillin-1 appears to be the same or in close proximity to that for LTBP-1. Immunohistochemical analysis of developing human aorta showed distinctive but extensively overlapping distributions for LTBPs-1 and -2. Both LTBPs showed extensive co-localization with fibrillin-1 and elastic lamellae but LTBP-2 had extensive signal throughout the medial layer whereas LTBP-1 showed strong localization only in the outer medial layer. The finding indicates that there is a possibility for LTBP-2 to compete with LTBP-1 for binding to fibrillin-containing microfibrils throughout the aortic wall but particularly in the outer medial region where the LTBP-1 is predominantly located. Overall, the results support the concept that that LTBP-2 may be an indirect negative modulator for storage of the large latent TGF-beta complex on microfibrils in aorta and other fibrillin-rich tissues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17293099     DOI: 10.1016/j.matbio.2006.12.006

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  51 in total

1.  Fibrillin-containing microfibrils are key signal relay stations for cell function.

Authors:  Karina A Zeyer; Dieter P Reinhardt
Journal:  J Cell Commun Signal       Date:  2015-10-08       Impact factor: 5.782

Review 2.  Elastic fibers and biomechanics of the aorta: Insights from mouse studies.

Authors:  Hiromi Yanagisawa; Jessica Wagenseil
Journal:  Matrix Biol       Date:  2019-03-15       Impact factor: 11.583

Review 3.  FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders.

Authors:  Lynn Y Sakai; Douglas R Keene; Marjolijn Renard; Julie De Backer
Journal:  Gene       Date:  2016-07-18       Impact factor: 3.688

4.  Human eye development is characterized by coordinated expression of fibrillin isoforms.

Authors:  Dirk Hubmacher; Dieter P Reinhardt; Thomas Plesec; Katja Schenke-Layland; Suneel S Apte
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-18       Impact factor: 4.799

Review 5.  The microfibril hypothesis of glaucoma: implications for treatment of elevated intraocular pressure.

Authors:  John Kuchtey; Rachel W Kuchtey
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-12       Impact factor: 2.671

Review 6.  Biogenesis and function of fibrillin assemblies.

Authors:  Francesco Ramirez; Lynn Y Sakai
Journal:  Cell Tissue Res       Date:  2009-06-10       Impact factor: 5.249

7.  Defining elastic fiber interactions by molecular fishing: an affinity purification and mass spectrometry approach.

Authors:  Stuart A Cain; Amanda McGovern; Elaine Small; Lyle J Ward; Clair Baldock; Adrian Shuttleworth; Cay M Kielty
Journal:  Mol Cell Proteomics       Date:  2009-09-15       Impact factor: 5.911

8.  Tgfbeta2 and 3 are coexpressed with their extracellular regulator Ltbp1 in the early limb bud and modulate mesodermal outgrowth and BMP signaling in chicken embryos.

Authors:  Carlos I Lorda-Diez; Juan A Montero; Juan A Garcia-Porrero; Juan M Hurle
Journal:  BMC Dev Biol       Date:  2010-06-21       Impact factor: 1.978

9.  LTBP2 null mutations in an autosomal recessive ocular syndrome with megalocornea, spherophakia, and secondary glaucoma.

Authors:  Julie Désir; Yves Sznajer; Fanny Depasse; Françoise Roulez; Marc Schrooyen; Françoise Meire; Marc Abramowicz
Journal:  Eur J Hum Genet       Date:  2010-02-24       Impact factor: 4.246

10.  Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries.

Authors:  Mark J Prodoehl; Nicholas Hatzirodos; Helen F Irving-Rodgers; Zhen Z Zhao; Jodie N Painter; Theresa E Hickey; Mark A Gibson; William E Rainey; Bruce R Carr; Helen D Mason; Robert J Norman; Grant W Montgomery; Raymond J Rodgers
Journal:  Mol Hum Reprod       Date:  2009-08-19       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.